The burden of heart failure (HF) continues to grow, making HF one of the single most expensive and deadly health care problems in the United States today. Medical therapies and non-pharmacologic measures for HF can reduce patients' need for re-hospitalization, lower costs of care, and improve survival. Unfortunately, these strategies are underutilized in conventional practice settings. Dr. Fonarow addresses multidisciplinary pathways to implement evidence-based HF therapies that optimize the care of patients with HF, including measures to prevent HF from developing in patients at risk
Notes
Title from resource description page (viewed February 01, 2016)